ConductScience.org, home

Paper40705331

Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer.

de Nijs K and 8 others. JAMA Netw Open, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer. Papers, record 40705331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40705331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer.
PubMed
Journal
JAMA Netw Open
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-06-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Nijs KKoen
2de Koning HJHarry J
3Cao PPianpian
4Diasparra MMaikol
5Garner RRochelle
6Jeon JJihyoun
7Yong JHEJean H E
8Meza RRafael
9Ten Haaf KKevin

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lung NeoplasmsMajor topic
Tomography, X-Ray ComputedMajor topic
Early Detection of CancerMajor topic
Mass ScreeningMajor topic
Humans
Aged
Male
Female
Middle Aged
Cost-Benefit Analysis
Aged, 80 and over
Canada
Quality-Adjusted Life Years
Smoking
United States
Risk Factors

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U01 CA253858NCI NIH HHSUnited StatesU01CA253858PubMed

Source NIH RePORTER

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136653232Patterns of Birth Cohort‒Specific Smoking Histories by Race and Ethnicity in the U.S.Am J Prev Med2023https://conductscience.org/library/papers/36653232PubMed
237792671Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland.Int J Cancer2024https://conductscience.org/library/papers/37792671PubMed
334673885Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.JAMA Oncol2021https://conductscience.org/library/papers/34673885PubMed
433687470Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.JAMA2021https://conductscience.org/library/papers/33687470PubMed
531995683Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.N Engl J Med2020https://conductscience.org/library/papers/31995683PubMed
635989646Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study.J Med Screen2022https://conductscience.org/library/papers/35989646PubMed
734673888Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.JAMA Oncol2021https://conductscience.org/library/papers/34673888PubMed
833687469Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.JAMA2021https://conductscience.org/library/papers/33687469PubMed
936436778Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough.J Am Coll Radiol2023https://conductscience.org/library/papers/36436778PubMed
1037909874Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: A simulation modeling study.Cancer2024https://conductscience.org/library/papers/37909874PubMed
1139764179Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation study.EClinicalMedicine2024https://conductscience.org/library/papers/39764179PubMed
1234383299A risk-based framework for assessing real-time lung cancer screening eligibility that incorporates life expectancy and past screening findings.Cancer2021https://conductscience.org/library/papers/34383299PubMed
1334668948Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States.JAMA Netw Open2021https://conductscience.org/library/papers/34668948PubMed
1437909877Screening for lung cancer: 2023 guideline update from the American Cancer Society.CA Cancer J Clin2024https://conductscience.org/library/papers/37909877PubMed
1521714641Reduced lung-cancer mortality with low-dose computed tomographic screening.N Engl J Med2011https://conductscience.org/library/papers/21714641PubMed
1636745885Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis.Ann Intern Med2023https://conductscience.org/library/papers/36745885PubMed
1734164288Lung cancer screening in Europe: where are we in 2021?Transl Lung Cancer Res2021https://conductscience.org/library/papers/34164288PubMed
1825670839Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.Med Decis Making2015https://conductscience.org/library/papers/25670839PubMed
1923064024How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access.Prev Med2012https://conductscience.org/library/papers/23064024PubMed
2038813448Projected effectiveness of lung cancer screening and concurrent smoking cessation support in the Netherlands.EClinicalMedicine2024https://conductscience.org/library/papers/38813448PubMed

See all 37 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42487098Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.Pharmacoeconomics2026https://conductscience.org/library/papers/42487098PubMed
41833807Integrating Deep Learning of Low-Dose CT Imaging With Clinical Data for Lung Cancer Risk Prediction.Chest2026https://conductscience.org/library/papers/41833807PubMed
41499175Geospatial Analysis of Accredited Lung Cancer Screening Facilities in Florida Reveals Suboptimal Alignment with High-Risk Populations.Cancer Res Commun2026https://conductscience.org/library/papers/41499175PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40705331

GET https://conductscience.org/api/papers/v1/40705331/references?page=2